SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914190-08-000554
Filing Date
2008-06-18
Accepted
2008-06-18 14:09:56
Documents
1
Period of Report
2008-06-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5682
  Complete submission text file 0000914190-08-000554.txt   7661
Mailing Address 7000 SHORELINE COURT SUITE 370 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 370 SOUTH SAN FRANCISCO CA 94080 6505886404
Hana Biosciences Inc (Issuer) CIK: 0001140028 (see all company filings)

IRS No.: 841588441 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O LIGAND PHARMACEUTICALS INC., 10275 SCIENCE CENTER DR. SAN DIEGO CA 92121
Business Address 8585507577
MAIER PAUL V (Reporting) CIK: 0001182615 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32626 | Film No.: 08905357